tirzepatide and leg cramps on Mounjaro: Causes Management Tirzepatide Side Effects and Muscle

Semaglutide is a GLP-1 receptor agonist that has been approved by the FDA for the treatment of both type 2 diabetes and obesity

The FDA is proposing to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which identifies bulk drug substances that outsourcing facilities may use in compounding when there is a clinical need

So normal people don't really "store" it but most is not lost

Incretin mimetics engage both the extracellular and transmembrane domains (TMD) of GLP-1R, whereas small molecule GLP-1R agonists are more restricted to the traditional GPCR binding pocket in the TMD 8,9,10,11